For 29 SS patients, both cutaneous and blood samples were available (median time between samples = 4.5 months [range: 0–55.2]) which analysis revealed a moderate but positive correlation of CD39 expression between circulating CD4+ T cells and cutaneous lymphocytes (Figure 1e). The gene discussed is ENTPD1; the disease is synovial sarcoma.